Western Digital Corp Corporation (NASDAQ:WDC)’s CEO Stephen D. Milligan sold 15,996 shares of the company’s stock on the open market in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $95.88, for a total value of $1,533,696.48. Western Digital Corporation (NASDAQ:WDC) in last trading activity moved up 1.14% to close at $87.83. Company weekly performance is 1.57% while its quarterly performance stands at -11.95%. Western Digital Corporation (NASDAQ:WDC) is -14.80% away from its 52 week high. The circumstances under which the Board will entertain the inclusion of “supplemental evidence” in an inter partes review proceeding remains a moving target. It is worth noting, therefore, the case of Mentor Graphics Corp. v. Synopsys, Inc., (NASDAQ:SNPS) IPR2014-00287, wherein the Board denied Petitioner’s efforts to include Patent Owner’s infringement contentions from a co-pending district court litigation involving the same patent. Paper 17 at 2. Petitioner claimed that these contentions reflect Patent Owner’s assessment of the claim scope. Id. On last trading day Synopsys Inc. (NASDAQ:SNPS) moved up 0.71% to close at $38.10. Its volatility for the week is 2.08% while volatility for the month is 1.85%. SNPS's sales growth for past 5 years was 8.00% and its EPS growth for past 5 years was 4.10%. Synopsys Inc. (NASDAQ:SNPS) monthly performance is -6.75%. HealthStream Inc. (NASDAQ:HSTM) issued its quarterly earnings data on Monday. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.08 by $0.05. On last trading day Healthstream Inc. (NASDAQ:HSTM) moved up 0.33% to close at $24.37. Its volatility for the week is 6.74% while volatility for the month is 4.30%. HSTM's sales growth for past 5 years was 20.70% and its EPS growth for past 5 years was 18.20%. Healthstream Inc. (NASDAQ:HSTM) monthly performance is -2.91%. The drug developer ChemoCentryx, Inc. (NASDAQ:CCXI) reported positive data from a late-stage trial on its experimental drug vercirnon, a potential treatment for Crohn's disease. Patients given the drug twice daily experienced improved response and remission rates than those on a once-a-day dosage. ChemoCentryx, Inc. (NASDAQ:CCXI) has 5.00% insider ownership while its institutional ownership stands at 67.10%. In last trading activity company's stock closed at $5.34. Recently, Gentiva Health Services Inc. (NASDAQ:GTIV) has approved to be in use above by Kindred Healthcare Inc. (KND). The five month extended offer has lastly approach to an open permission at a buy concern of 720 million dollar consisting mutually cash and stock. With the supposition of Gentiva’s debt, sum consideration of the contract is prized at 1.8 billion dollar. On Monday shares of Gentiva Health Services Inc. (NASDAQ:GTIV) closed at $19.39. Company's sales growth for last 5 years was 6.90% and EPS growth for next 5 years is recorded as 10.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
